AI Breakthrough Helps Doctors Spot Pregnancy Risks Earlier

When Robhy Bustami watched his mother—an obstetrician with decades of experience—struggle to interpret unclear ultrasound images, he saw an opportunity to merge medicine with technology. That moment led to BioticsAI, whose groundbreaking software just received FDA approval after nearly three years of development.

Family Roots Inspire Medical Innovation

Growing up surrounded by obstetricians gave Bustami unique insight into prenatal care's challenges. "Even the most experienced doctors can miss things when images aren't perfect," he explains. His solution? Artificial intelligence that acts like a second pair of trained eyes during ultrasounds.

How the Technology Works

The system performs three crucial functions:

• Instant quality checks during scans to ensure doctors capture all necessary angles
• Automated measurements that populate medical records automatically
• Specialized training on diverse patient groups to reduce diagnostic disparities

What sets it apart is its focus on populations often underserved by current technology. "Black mothers face significantly higher risks," Bustami notes. "We built our models to recognize abnormalities across all ethnicities."

The Long Road to Approval

The FDA clearance didn't come easily. Most health tech startups develop first and seek approval later—but BioticsAI took a different approach. "We designed every component with regulators at the table," says Bustami. This meant slower progress initially but created a product that met stringent requirements from day one.

The result: software that reduces human error while fitting seamlessly into existing hospital workflows.

What This Means for Expectant Parents

The technology won't replace doctors but will give them powerful new tools. Imagine getting clearer answers about your baby's development sooner—that's the promise here.

The company plans to expand features soon, potentially detecting more conditions earlier in pregnancy.

Key Points:

• FDA-approved AI analyzes ultrasound scans in real time
• Developed by team with deep obstetrics experience
• Specifically trained on diverse patient populations
• Three-year approval process focused on regulatory compliance from start
• Could significantly improve early detection of fetal abnormalities